Recall Record

Lincoln, RI, United States

Denison Pharmaceuticals, LLC recalls

4 recalls recorded since 2018, most recently on 24 February 2025. 3 are listed as ongoing. Status and classification are as published by the FDA.

Recalls4
Ongoing (FDA)3
Terminated or completed1
Class I (FDA)0

Ongoing Class II Drugs

Recall started
24 February 2025
Reason
Chemical Contamination: Presence of benzene.
Distribution
Nationwide within the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0273-2025

Ongoing Class III Drugs

Recall started
25 September 2024
Reason
Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.
Distribution
Product was distributed to two accounts that may have distributed the product further to the Retail Level.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0033-2025, D-0034-2025

Terminated Class II Drugs

Recall started
28 May 2024
Terminated
26 August 2025
Reason
cGMP deviations: Test results confirmed aypical Burkholderia Cepacia were a result of personnel error.
Distribution
Recalled units were distributed to one customer. 100% recovered (113,544 units) and controlled at Denison Pharmaceuticals.
Initiated
Voluntary: Firm initiated
Recall number
D-0557-2024

Ongoing Class II Drugs

Recall started
3 May 2023
Reason
CGMP Deviations: Use of non-food grade lubricant in mixing vessel.
Distribution
Product was distributed Nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0774-2023, D-0775-2023, D-0773-2023, D-0772-2023

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.